Optiscan Imaging ROE 2024

Optiscan Imaging Aktienanalyse

What does Optiscan Imaging do?

Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Optiscan Imaging's Return on Equity (ROE)

Optiscan Imaging's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Optiscan Imaging's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Optiscan Imaging's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Optiscan Imaging’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Optiscan Imaging stock

What is the ROE (Return on Equity) of Optiscan Imaging this year?

The ROE of Optiscan Imaging this year is -0.44 undefined.

How has the Return on Equity (ROE) of Optiscan Imaging developed compared to the previous year?

The ROE of Optiscan Imaging has increased by -31.94% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Optiscan Imaging?

A high ROE indicates that Optiscan Imaging generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Optiscan Imaging?

A low ROE can indicate that Optiscan Imaging is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Optiscan Imaging affect the company?

A change in ROE (Return on Equity) of Optiscan Imaging can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Optiscan Imaging?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Optiscan Imaging?

Some factors that can influence Optiscan Imaging's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Optiscan Imaging pay?

Over the past 12 months, Optiscan Imaging paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Optiscan Imaging is expected to pay a dividend of 0 AUD.

What is the dividend yield of Optiscan Imaging?

The current dividend yield of Optiscan Imaging is .

When does Optiscan Imaging pay dividends?

Optiscan Imaging pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Optiscan Imaging?

Optiscan Imaging paid dividends every year for the past 0 years.

What is the dividend of Optiscan Imaging?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Optiscan Imaging located?

Optiscan Imaging is assigned to the 'Health' sector.

Wann musste ich die Aktien von Optiscan Imaging kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Optiscan Imaging from 9/19/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Optiscan Imaging pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Optiscan Imaging in the year 2023?

In the year 2023, Optiscan Imaging distributed 0 AUD as dividends.

In which currency does Optiscan Imaging pay out the dividend?

The dividends of Optiscan Imaging are distributed in AUD.